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Metabolic syndrome is associated with reduced endothelial vasodilator function. It is also 
associated with the induction of cyclooxygenase-2 (COX2), which produces vasoactive 
prostanoids. The frequency of metabolic syndrome increases with age and aging per se is 
a risk factor associated with reduced endothelium-mediated relaxation. Nevertheless, the 
combined effect of aging and metabolic syndrome on the endothelium is less known. We 
hypothesized that COX2 derived prostanoids may affect endothelium function in metabolic 
syndrome associated with aging. We used obese Zucker rats, a model of metabolic syndrome. 
First order mesenteric arteries were isolated from 4- and 12-month-old rats and acetylcholine 
(endothelium)-dependent relaxation determined using wire-myography. Endothelium-mediated 
relaxation, impaired in young Zucker rats (89 versus 77% maximal relaxation; lean versus 
Zucker), was further reduced in old Zucker rats (72 versus 51%, lean versus Zucker). The effect 
of the nitric oxide-synthesis inhibitor L -NAME on the relaxation was reduced in both young 
and old Zucker rats without change in eNOS expression level. COX inhibition (indomethacin) 
improved acetylcholine-mediated relaxation in old obese rats only, suggesting involvement of 
vasoconstrictor prostanoids. In addition, COX2 inhibition (NS398) and TxA2/PGH2 receptor 
blockade (SQ29548) both improved relaxation in old Zucker rat arteries. Old Zucker rats had the 
highest TxB2 (TxA2 metabolite) blood level associated with increased COX2 immunostaining. 
Chronic COX2 blockade (Celecoxib, 3 weeks) restored endothelium-dependent relaxation in old 
Zucker rats to the level observed in old lean rats. Thus the combination of aging and metabolic 
syndrome further impairs endothelium-dependent relaxation by inducing an excessive production 
of COX2-derived vasoconstrictor(s); possibly TxA2.
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vascular impairment. Indeed, metabolic syndrome is also associated 
with increased thromboxane A2 (TXA2)-mediated vasoconstric-
tion and endothelium dysfunction (Xiang et al., 2006, 2008). These 
studies suggest that COX2 might be involved in this production 
of TXA2.
Aging, per se is also associated to a gradual endothelium dys-
function both in human (Egashira et al., 1993; Taddei et al., 1995) 
and animal models of aging (Koga et al., 1989; Kung and Luscher, 
1995). Again, an excessive ROS production reduces NO bioavail-
ability (Wenzel et al., 2008; Herrera et al., 2010). Nevertheless, the 
involvement of COX2-derived prostanoids remains a matter of con-
troversy. Several studies have reported an increased COX2-derived 
TXA2 production with aging, attenuating endothelium-mediated 
vasorelaxation (Koga et al., 1989) while other studies (Kung and 
Luscher, 1995) argued for an increase ROS production only. A 
recent study using a mouse model of obesity reported that aging 
up-regulates expression of inflammatory mediators in adipose tis-
sues and showed an increased COX2 expression level (Wu et al., 
2007). Nevertheless, no study has yet investigated the concomitant 
effect of aging and metabolic syndrome on the endothelium and 
its vasodilator capacity. The purpose of the present study was thus 
IntroductIon
Obesity is a fast growing problem worldwide (James, 2004) and is 
associated with an increasing risk of cardiovascular morbidity and 
mortality, especially when it is associated with other risk factors 
in the metabolic syndrome (Hu et al., 2004). However, the root 
causes of cardiovascular dysfunction associated with the metabolic 
syndrome still remain poorly defined (Krentz et al., 2009). The 
endothelium regulates vascular tone through the production of 
nitric oxide (NO), prostacyclin and hyperpolarizing factors. The 
endothelium is affected in metabolic syndrome (Eckel et al., 2005; 
Frisbee and Delp, 2006). Indeed, studies in human (Arkin et al., 
2008) or in obese Zucker rats, a model of hyperphagia-induced 
metabolic syndrome, have reported endothelium dysfunction in 
several vascular beds (Zanchi et al., 1995) associated with a reduced 
NO bioavailability (Bohlen, 2004). Resistance arteries are strongly 
affected in metabolic disorders (Frisbee and Stepp, 2001; Stepp 
et al., 2004; Frisbee and Delp, 2006; Krentz et al., 2009) due to 
increased reactive oxygen species (ROS) production and conse-
quently reduced NO bioavailability (Phillips et al., 2005; Busija 
et  al.,  2006;  Roberts  et  al.,  2006).  Several  studies  suggest  that 
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in TBST. Protein expression was visualized using the ECL-Plus 
Chemiluminescence  kit  (Amersham)  (Belin  de  Chantemele 
et al., 2009).
Immuno-hIstologIcal detectIon of coX2
Cyclooxygenase-2 immunolabeling was performed as previously 
described (Henrion et al., 1997; Retailleau et al., 2010). Briefly, seg-
ments of mesenteric arteries were mounted in embedding medium 
(Tissu-Tek, Miles, Inc.), frozen in isopentane pre-cooled in liquid 
nitrogen, and stored at −80°C. Primary goat anti-COX2 polyclonal 
antibodies (1/200, Santa Cruz Biotechnology) were applied on the 
cross-sections (7 μm thick) followed by the fluorescent secondary 
antibody (1/200, Fluoroprobes). In negative control experiments 
the primary antibody was omitted. Positive control experiments 
were performed using mesenteric arteries from lipopolysaccharide-
treated rats (Belin de Chantemele et al., 2010). Positive staining 
was visualized using confocal microscopy and QED-Image soft-
ware (Solamere Technology). Image analysis was performed using 
Histolab (Microvision). The auto-fluorescent internal and external 
laminas, excluded for the fluorescence quantification, were used 
to delimit the media. Care was taken to take all the pictures in the 
same condition of laser power, gain, and exposure time.
Blood prostanoIds measurement
Blood samples were withdrawn from the femoral artery and placed 
in ice-cold polypropylene tubes containing EDTA plus indometh-
acin and centrifuged immediately at 3000 rpm for 15 min at 4°C 
and then stored at −80°C. Plasma samples were acidified with glacial 
acetic acid to pH 3 and then applied to octadecylsilyl (ODS) silica 
columns, washed with 15% aqueous ethanol and petroleum ether. 
The prostanoids were eluted with methyl formate. The eluent was 
evaporated to dryness under vacuum and the residue was dissolved 
in 400 L assay buffer. Thromboxane B2, 6-keto-PGF1alpha, and 
8-isoprostane concentrations were measured using commercially 
available  kits  (Cayman  Chemical).  Hydrolysis  with  KOH  15% 
(40°C, 60 min followed by KH2PO4 1 M) was performed before 
8-isoprostane measurement). The total prostanoids concentration 
was measured as pg/mL.
hIstologIcal analysIs
In order to determine the cross-sectional area of mesenteric arteries, 
blood vessels were dissected under a microscope, mounted between 
two  glass  micropipettes  and  submitted  to  intraluminal  pressure 
(100 mmHg). Arteries were bathed in a calcium-free PSS containing 
SNP (10 μmol/L). Arteries were then fixed in CARSON solution and 
embedded in Epon E812 resin. Semi-thin sections were stained with 
toluidine blue and observed under a DMR microscope (Leica). Image 
analysis was performed as previously described using the Histolab soft-
ware (Microvision, Paris, France) (Belin de Chantemele et al., 2009).
statIstIcal analysIs
Results are expressed as mean ± SEM. Significance of the difference 
between arteries was determined by ANOVA (one-factor ANOVA or 
ANOVA for consecutive measurements, when appropriate). Mean 
values were compared by unpaired t-test or by the Bonferroni test 
for multigroup comparisons. Values of P < 0.05 were considered 
to be significant.
to assess the effect of aging associated with metabolic syndrome 
on endothelium-mediated relaxation. We hypothesized that in old 
obese rats COX2 derived prostanoids may further impair endothe-
lium-mediated  dilation.  We  compared  acetylcholine-mediated 
relaxation in first order mesenteric arteries isolated from young 
and old obese Zucker rats, a model of metabolic syndrome, and 
defined the mechanism involved in the alteration observed.
materIals and methods
anImals
Three- and 12-month-old male lean and obese Zucker rats were 
purchased from Charles River (L’Arbresles, France) and anesthe-
tized (Isoflurane, 2.5%). The right femoral artery was then can-
nulated for blood pressure measurement as previously described 
(Ben Driss et al., 2000). Animals were then sacrificed by CO2 inha-
lation after collecting blood on heparin. The gut excised and the 
mesenteric arteries gently dissected. Blood glucose was measured 
as previously described (Frisbee and Stepp, 2001; Katakam et al., 
2005; Bouvet et al., 2007).
In a separated series of experiments 12-month-old male lean and 
obese Zucker rats were treated with the COX2 inhibitor Celecoxib 
(25 mg/kg/day, forced feeding once a day, 21 days).
The  procedure  followed  in  the  care  and  euthanasia  of  the 
study animals was in accordance with the European Community 
Standards on the Care and Use of Laboratory Animals (Ministère 
de l’Agriculture, France, authorization No. 6422).
pharmacologIcal profIle of the arterIes
First order mesenteric arteries were isolated and mounted on 
a  wire-myograph  (DMT,  Aarhus,  Denmark),  as  previously 
described (Henrion et al., 1992; Loufrani et al., 2002). Briefly, 
two tungsten wires (25 μm diameter) were inserted in the lumen 
of the arteries and fixed to a force transducer and a microm-
eter, respectively. A wall tension equivalent to a pressure of 
100 mmHg was then applied. Arteries were bathed in a physi-
ological salt solution (PSS) maintained at a pH of 7.4, a PO2 
of 160 mmHg and a PCO2 of 37 mmHg. Cumulative concen-
tration–response curves to acetylcholine were contracted with 
phenylephrine (1–3 μmol/L in order to reach 50% of maximal 
contraction) (Loufrani et al., 2002). Cumulative concentration–
response curves were repeated after addition of one of the fol-
lowing agent: the NO-synthase blocker L-NAME (100 μmol/L), 
the non-specific COX inhibitor indomethacin (10 μmol/L), the 
COX2 inhibitor NS398 (10 μmol/L) or the TXA2/PGH2 (TP) 
receptor antagonist SQ29548 (10 μmol/L) (Racz et al., 2009). 
Endothelium-independent vasorelaxation was assessed with a 
CRC to sodium nitroprusside (SNP). Contraction to phenyle-
phrine (1 nmol/L to 10 μmol/L) and to U46619 (stable TxA2 
mimetic, 1 nmol/L to 10 μmol/L) (Bolla et al., 2002) was assessed 
on a different arterial segment.
Western Blot analysIs
Arterial segments were homogenized and proteins (25 μg total pro-
tein from each sample) were separated by SDS-PAGE using a 4% 
stacking gel followed by a 10% running gel. Proteins were detected 
with  specific  antibodies  directed  against  eNOS  (Transduction 
Laboratories) 1:1000 or COX2 (1:500, Santa Cruz Biotechnology) www.frontiersin.org  November 2010  | Volume 1  | Article 145  |  3
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mediated vasorelaxation in old lean animals (Figure 1B), whereas 
indomethacin increased acetylcholine-mediated vasorelaxation in 
old obese Zucker rats (Figure 1B).
Precontraction prior to the addition of acetylcholine was similar 
in the four groups (Figure 1D).
The endothelium dysfunction associated with metabolic syn-
drome, aging, or the combination of aging plus metabolic syn-
drome  was  not  associated  with  a  change  in  eNOS  expression 
level (Figure 1E).
Endothelium-independent relaxation (SNP) was not affected 
by aging or by metabolic syndrome (Figure 2A).
contractIlIty
Contraction to phenylephrine was not affected by aging or chronic 
COX2 inhibition (data not shown) whereas contraction to U46619 
was significantly higher in 12-month-old obese Zucker rats (maxi-
mal contraction: 16 ± 1.6 mN, n = 8) than in 12-month-old lean 
rats (11 ± 1.2 mN, n = 8) or than in 3-month-old rats (10 ± 1.4 mN 
in lean rats and 12 ± 1.4 mN in obese rats, n = 10 per group). In 
12-month-old lean rats chronically treated with Celecoxib, U46619-
induced contraction was significantly reduced (11 ± 1.5 mN, n = 8). 
The EC50 for U46619 was not affected by aging or metabolic syn-
drome (data not shown).
Vascular remodelIng
Arterial  (luminal)  diameter  was  reduced  in  obese  Zucker  rats 
compared to lean rats (significant in young animals only) and 
increased in old compared to young rats (Figure 2B). By contrast, 
media cross-section was higher in obese Zucker rats than in lean 
rats (again, significant in young animals only) and higher in old 
than in young rats (Figure 2C). Media to lumen ratio was signifi-
cantly higher in old Zucker obese rats compared to lean animals 
(Figure 2D). In celecoxib-treated old rats media to lumen ratio 
remained significantly higher in old Zucker obese rats compared 
to lean animals (0.94 ± 0.11 in obese Zucker rats versus 0.63 ± 0.09 
in lean rats, n = 8 per group, P < 0.05).
role of coX2 derIVed prostanoIds In endothelIum-medIated 
relaXatIon
Acute COX2 inhibition with NS398 did not affect acetylcholine-
mediated relaxation in young lean and obese Zucker rats but sig-
nificantly improved acetylcholine-mediated relaxation in old obese 
Zucker rats (Figure 3A). No effect of NS398 was observed in old 
lean rats (Figure 3A).
TP receptor inhibition with SQ29548 did not affect acetylcho-
line-mediated vasorelaxation in young lean and obese Zucker rats 
while it significantly improved endothelium-dependent relaxation 
in old obese Zucker rats (Figure 3B).
In old obese Zucker rats plasma TxB2 (stable metabolite of TxA2), 
6-keto-PGF1alpha (stable métabolite of PGI2) and 8-isoprostane 
were significantly higher than in young rats (lean or obese) and 
than in old lean rats (Figure 4). In old obese Zucker rats chronically 
treated with Celecoxib plasma plasma TxB2 and 6-keto-PGF1alpha 
was reduced to the level found in lean animals. The treatment did 
not significantly change blood 8-isoprostane level. In young obese 
Zucker rats blood TxB2 was not significantly higher than in young 
lean rats (Figure 4).
Table 1 | Body weight, mean arterial pressure, and blood glucose 
measured in lean and obese Zucker rats aged 4 or 12 months.
  Lean rats  Obese Zucker rats
Age (months)  4  12  4  12
VehicLe-TreATed rATs
Body weight (g)  335 ± 11  388 ± 14*  527 ± 28*  721 ± 29*#
Mean arterial  97 ± 3  103 ± 4  101 ± 5  123 ± 6*# 
pressure (mmHg)
Blood glucose  8.6 ± 0.7  8.99 ± 0.9  9.58 ± 0.9  12.38 ± 1.0*# 
(mmol/L)
ceLecOxiB-TreATed rATs
Body weight (g)    391 ± 12*    696 ± 34*#
Mean arterial    101 ± 3*    126 ± 5*# 
pressure (mmHg)
Blood glucose    8.2 ± 1.0    13.11 ± 1.2*# 
(mmol/L)
Rats were treated with the COX2 inhibitor Celecoxib or not (mean ± SEM, n = 8 
per group).
*P < 0.05, young or old obese Zucker versus young lean rats.
#P < 0.05, old obese Zucker rats versus old lean rats.
results
physIologIcal parameters
Rat body weight was significantly higher in obese Zucker rats than 
in lean rats, independent of age, and body weight was higher in 
12-month-old rats than in young rats (Table 1). Mean arterial blood 
pressure was not affected by aging in lean rats or by metabolic syn-
drome in young animals. Nevertheless, mean arterial pressure was 
slightly, but significantly, increased in old obese Zucker rats compare 
to young or old lean animals. Blood glucose was not significantly 
affected by aging in lean rats and by metabolic syndrome in young 
animals. However glycemia was significantly increased in old obese 
Zucker rats compared to young or old lean rats (Table 1).
endothelIum functIon
Acetylcholine  induced  a  concentration-dependent  relaxation 
in isolated mesenteric arteries. Acetylcholine-mediated relaxa-
tion was significantly reduced in obese Zucker rats compared 
to lean rats and the combination of metabolic syndrome and 
aging  further  impaired  endothelium-dependent  relaxation 
(Figures 1A,B).
NO-synthesis inhibition with L-NAME reduced acetylcholine-
mediated relaxation. Aging did not significantly affect the inhibi-
tory effect of L-NAME in lean rats. On the other hand, in both 
young and old obese Zucker rats the inhibitory effect of L-NAME 
was  significantly  reduced  compared  to  lean  rats  (Figure  1B). 
Indeed, acetylcholine-mediated maximal relaxation was inhibited 
by 78 ± 7% in young lean rats (Figure 1C) and by 49 ± 6% in young 
obese Zucker rats. L-NAME inhibited the relaxation by 75 ± 7% 
in old lean rats and by 56 ± 6% in old obese Zucker rats (P < 0.05 
versus lean).
Indomethacin did not significantly affect acetylcholine-medi-
ated relaxation in young obese Zucker and lean rats (Figure 1A). 
On the other hand, indomethacin further reduced acetylcholine-Frontiers in Physiology  |  Vascular Physiology    November 2010  | Volume 1  | Article 145  |  4
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Figure 1 | Acetylcholine-mediated relaxation in mesenteric resistance 
arteries isolated from young (A) or old (B) lean and obese Zucker rats. 
Concentration–response curves to acetylcholine were repeated after 
incubation with L-NAME (LN) and then with L-NAME plus indomethacin 
(LN + indo). Bargraphs (c) represent the maximal relaxation obtained in each 
group (taken from A and B). (d) Precontraction applied to the arteries before 
adding acetylcholine. (e) eNOS and β-actin expression level determined using 
Western blot. Mean ± SEM is presented (n = 8 per group). *P < 0.01, old 
versus young rats. #P < 0.01, obese versus lean rats. $P < 0.01, indo 
versus LN.www.frontiersin.org  November 2010  | Volume 1  | Article 145  |  5
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rats chronically treated with celecoxib, SQ29548 (Figure 6) and 
NS398 (data not shown) had no significant effect on acetylcholine-
mediated dilation.
dIscussIon
The novel finding of the present study is that the combined effect of 
metabolic syndrome and aging in a rat model, the obese Zucker rat, 
further impaired endothelium-dependent dilation due to COX2-
dependent production of TxA2.
Endothelium-mediated  relaxation  was  lower  in  old  rats, 
especially in old obese Zucker rats, in agreement with previous 
studies although they were performed in young obese Zucker 
rats (Frisbee and Stepp, 2001; Katakam et al., 2005; Bouvet 
et al., 2007) or old control, or lean, rats (Ishida et al., 2003; 
The presence of COX2 was confirmed using   immunostaining 
and Western blot (Figure 5). Both metabolic syndrome and aging 
were associated with an increased COX2 expression, which was 
further  enhanced  by  the  combination  of  metabolic  syndrome 
and aging. The endothelium and the smooth muscle layers were 
both labeled.
To confirm the role of COX2 in the impaired endothelium 
function,  old  obese  Zucker  rats  were  treated  chronically  with 
the COX2 inhibitor Celecoxib. Chronic Celecoxib restored the 
endothelium function in old obese Zucker rats without signifi-
cantly affecting acetylcholine-mediated relaxation in old lean rats 
(Figure 6). In both lean and obese old Zucker rats L-NAME abol-
ished acetylcholine-mediated dilation and indomethacin had no 
significant effect (Figure 6). Similarly, in lean and obese old Zucker 
Figure 2 | sodium nitroprusside-mediated relaxation in mesenteric arteries isolated from lean and obese Zucker rats aged 3 (young) or 12 months (old) 
(A). Luminal diameter, media cross-section, and media/lumen ratio are shown in (B–d) respectively. Mean ± SEM is presented (n = 8 per group). *P < 0.01, old 
versus young rats. #P < 0.01, obese versus lean rats.Frontiers in Physiology  |  Vascular Physiology    November 2010  | Volume 1  | Article 145  |  6
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Dumont et al., 2008). Similarly, acetylcholine-mediated relaxa-
tion is reduced in 7-month-old obese Zucker rats compared 
to 5-month-old animals (Subramanian and MacLeod, 2003). 
We also found a reduction in L-NAME sensitive endothelium-
mediated relaxation in both young and old obese Zucker rats. 
Although L-NAME blocks selectively NO-dependent dilation, 
this reduction was not associated with a change in eNOS expres-
sion level. This is in agreement with previous works performed 
in 2-year-old rats (Yan et al., 2007; Dumont et al., 2008) and in 
young obese Zucker rats (Karagiannis et al., 2003; Bouvet et al., 
2007). Vascular smooth muscle cells response to the NO donor 
SNP was similar in the different groups, in agreement with pre-
vious studies (Steinberg et al., 1996; Oltman et al., 2005, 2006; 
Dumont et al., 2008). Thus observation suggests that vascular 
smooth muscle cells sensitivity to NO was not affected by aging 
or metabolic syndrome.
In lean old rats, part of the dilation was sensitive to indometh-
acin, suggesting the involvement of vasodilator prostanoids, in 
agreement with a previous study in older rats (Heymes et al., 2000). 
Relaxation resistant to L-NAME and indomethacin in young rats 
and in old obese Zucker rats was probably due to EDHF as previ-
ously shown in various vascular territories (Feletou and Vanhoutte, 
2009). In addition, EDHF-dependent relaxation is reduced in obese 
Zucker mesenteric arteries (Young et al., 2008). Nevertheless, this 
issue was not investigated in the present study which focused on 
the involvement of COX-derived prostanoids.
Figure 3 | effect of cOx2 inhibition with Ns398 (A) or TxA2/PGH2 receptor blockade with SQ29548 (B) on acetylcholine-mediated relaxation in mesenteric resistance 
arteries isolated from young (A) or old (B) lean and obese Zucker rats. Mean ± SEM is presented (n = 8 per group). *P < 0.01, effect of NS398 (A) or SQ29548 (B).www.frontiersin.org  November 2010  | Volume 1  | Article 145  |  7
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Figure 4 | Plasma TxB2 (A), 6-keto-PgF1alpha (B), 8-isoprostane (c) in 3- and 12-month-old lean or obese Zucker rats. Rats were treated with the COX2 
inhibitor Celecoxib (Cel) or its solvent (Solv). Mean ± SEM is presented (n = 8 per group). *P < 0.01, obese versus lean rats. #P < 0.01, Celecoxib versus solvent.
traction was not affected. The relationship between COX2, adrenergic 
receptor and TP receptors remains to be further investigated. Our 
findings are in agreement with previous reports in old rats (Briones 
et al., 2005; Gendron et al., 2007; Kang et al., 2007) and in both 
young (Dey et al., 2004) and old obese rats (Gendron et al., 2007) 
showing the involvement of COX2-derived vasoconstrictor agents 
in old rats. Similarly, TxA2 impairs endothelium-mediated dilation 
In old obese Zucker rats indomethacin improved acetylcholine-
mediated relaxation, suggesting the involvement of vasoconstrictor 
prostanoids. This vasoconstrictor prostanoid is most likely TxA2 pro-
duced by COX2 as COX2 inhibition with NS398 and TxA2/PGH2 
receptor blockade with SQ29548 similarly improved relaxation. In 
addition, contraction induced by the TxA2 mimetic U49619 was 
higher in old obese Zucker rats whereas phenylephrine-induced con-
Figure 5 | (A) Detection of COX2 in mesenteric resistance arteries isolated 
from young or old lean and obese Zucker rats using immunostaining and 
confocal microscopy. A negative control was obtained by omitting the primary 
antibody (Neg. control) and a positive control was obtained using arteries from a 
lipopolysaccharide-treated rat (Pos. control). Quantification of the positive 
labeling is shown in the upper bargraph. (B) Quantitation of COX2 and β-actin 
using Western blot. Mean ± SEM is presented (n = 8 per group). *P < 0.01, old 
versus young rats. #P < 0.01, obese versus lean rats.Frontiers in Physiology  |  Vascular Physiology    November 2010  | Volume 1  | Article 145  |  8
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Old obese Zucker rat were slightly, but significantly hyper-
glycemic and hypertensive at the age of 12 months (Table 1), 
in agreement with previous studies (Oltman et al., 2005). 
Nevertheless, hyperglycemia in old Zucker rats (+30%) was 
much lower than in Zucker diabetic rats (3- to 4-fold increase) 
(Oltman et al., 2005). Hypertension in old obese Zucker was 
associated wit a significant increase in the media to lumen 
ratio, an index of wall hypertrophy. This was not observed in 
young rats. Although it is tempting to link the rise in blood 
pressure found in old obese Zucker rats excessive TxA2 pro-
duction, as previously shown (Matrougui et al., 1997, 2000), 
hypertension in old obese Zucker rats was not reduced by 
the chronic blockade of COX2. Several studies have shown 
that hyperglycemia is associated with an excessive produc-
tion of COX2-derived vasoconstrictor agents (Bagi et al., 2005; 
Matsumoto et al., 2007). Thus hyperglycemia, elevated in old 
obese Zucker rats, might be the cause, at least in part, of the 
induction of COX2 expression. Nevertheless, this issue remains 
of arteries of young obese Zucker rats in response to reduced oxygen 
tension (Goodwill et al., 2008). In addition, TxB2 blood level (the 
stable metabolite of TxA2) was elevated in young (Dey et al., 2004, not 
significant in the present study) and old (present study) obese Zucker 
rats. Furthermore, a simultaneous reduction in prostacyclin produc-
tion might increase endothelial dysfunction as previously shown in 
Zucker rats vascular cells (Hodnett et al., 2009). Nevertheless, blood 
levels of prostanoids, as measured in the present study, do not reflect 
vascular production only. Indeed blood measurements show that old 
obese Zucker rats have oxidative stress (increased isoprostane) and 
inflammation with systemic increased TxA2 and prostacyclin levels; 
one being vasoconstrictor, the other vasodilator. COX2 may produce 
both, at least in vascular cells (Wheeler-Jones, 2008; Retailleau et al., 
2010) and both were reduced by chronic celecoxib. This might, at least 
in part, explain the absence of effect of celecoxib on blood pressure 
in old obese Zucker rats. Nevertheless, the involvement of COX2-
derived TxA2 in old obese Zucker rats was confirmed in arteries of 
rats chronically treated with Celecoxib.
Figure 6 | Acetylcholine-mediated relaxation in mesenteric resistance 
arteries isolated from or old lean and obese Zucker rats (A). Rats were 
treated chronically with the COX2 inhibitor Celecoxib or its solvent. 
Mean ± SEM is presented (n = 8 per group). Acetylcholine-mediated 
relaxation was repeated in the presence of L -NAME (LN), L -NAME plus 
indomethacin (indo), or SQ29548 (SQ) and the effect is shown in the bargraph 
(B). *P < 0.01, effect of the chronic treatment with Celecoxib. #P < 0.001, 
effect of L -NAME.www.frontiersin.org  November 2010  | Volume 1  | Article 145  |  9
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